Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding
2026-04-30
This study demonstrates that naturally occurring angiotensin peptides, including Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to its host cell receptor AXL, a mechanism distinct from spike–ACE2 interactions. These findings suggest new molecular links between the renin–angiotensin system and viral pathogenesis, with potential implications for cardiovascular and infectious disease research.
-
Mechanisms of Cell Death in Heart Disease: Regulated Apoptos
2026-04-29
This article examines the pivotal findings of Konstantinidis et al. (2012), who delineate the regulated nature of both apoptosis and necrosis in cardiac cell death, challenging the traditional view of necrosis as exclusively passive. Their review integrates genetic, molecular, and pharmacological evidence to highlight overlapping pathways and therapeutic potential, with practical implications for fibrosis and inflammation research.
-
BET Bromodomain Inhibitor (+)-JQ1: Translational Impact & Sy
2026-04-29
Explore the translational impact of Bromodomain Inhibitor, (+)-JQ1, with a focus on its synergy with CDK4/6 inhibitors and applications in apoptosis, inflammation, and non-hormonal male contraception. Discover protocol nuances and novel mechanistic insights not covered in conventional workflows.
-
Toremifene Citrate: Mechanistic Insights for Assay Innovatio
2026-04-28
Explore Toremifene Citrate as a cutting-edge oral selective estrogen receptor modulator, with a focus on mechanistic assay design and translational research strategies. This article delivers advanced guidance for breast cancer and hormone receptor modulation studies.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan
2026-04-28
This study uncovers the central role of IGF2BP3 as an m6A RNA-binding protein that stabilizes FZD1/7 transcripts, sustaining cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). The findings highlight a targetable signaling axis with implications for overcoming chemoresistance and improving therapeutic outcomes in TNBC.
-
Ruthenium Red in Mechanotransduction: Precision for Cytoskel
2026-04-27
Explore how Ruthenium Red, a potent Ca2+ transport inhibitor, uniquely advances mechanotransduction and cytoskeleton-dependent autophagy research. This article delivers novel assay guidance and actionable insights not covered elsewhere.
-
Safe DNA Gel Stain: Precision, Photoprotection, and Practica
2026-04-27
Explore how Safe DNA Gel Stain enables precise DNA and RNA visualization while minimizing DNA damage and enhancing workflow safety. This article goes beyond standard reviews, offering deep scientific analysis and assay-centric guidance for molecular biology researchers.
-
Dexamethasone: Glucocorticoid Anti-inflammatory for Applied
2026-04-26
Dexamethasone (DHAP) from APExBIO enables precise control of inflammation and immune responses via targeted NF-κB inhibition and stem cell modulation. This guide delivers evidence-backed workflows, troubleshooting strategies, and insight into maximizing experimental reliability for inflammation and neuroinflammation research.
-
Griseofulvin and Microtubule Destabilization: Advanced Insig
2026-04-25
Explore how Griseofulvin, a microtubule associated inhibitor, enables advanced mechanistic assays in antifungal research. This article provides a deeper, data-driven perspective on microtubule disruption mechanisms and assay design, differentiating itself from standard workflow guides.
-
HotStart Universal 2X Green qPCR Master Mix: Specificity & B
2026-04-24
HotStart Universal 2X Green qPCR Master Mix (K1170) enables highly specific, dye-based real-time PCR gene expression analysis. It utilizes hot-start Taq polymerase with an antibody block for superior specificity and reproducibility, making it ideal for quantitative applications where precise DNA amplification monitoring is essential.
-
Biotin-tyramide: Amplifying Sensitivity in IHC and ISH Workf
2026-04-24
Biotin-tyramide empowers ultra-sensitive detection in immunohistochemistry and in situ hybridization by enabling robust, localized signal amplification. Explore how this biotin phenol-based reagent, supplied by APExBIO, transforms experimental workflows, troubleshooting, and advanced proximity labeling applications.
-
Recombinant Mouse Sonic Hedgehog: Applied Workflows & Troubl
2026-04-23
Recombinant Mouse Sonic Hedgehog (SHH) protein from APExBIO enables high-fidelity modeling of hedgehog pathway dynamics in limb, brain, and urogenital development studies. This guide translates the latest comparative research and validated protocols into actionable workflows and troubleshooting insights for developmental biology investigators.
-
Steroid-Induced Lysis of Bacterial Protoplasts: Mechanistic
2026-04-23
This article examines the landmark 1965 study by Smith and Shay using protoplasts of Sarcina lutea to dissect the lytic action of synthetic antimicrobial steroids and the modulatory effects of stabilizers and antagonists. The work provides mechanistic clarity on how direct interactions with bacterial membranes drive steroid-induced lysis, influencing subsequent research on membrane-targeting antimicrobial strategies.
-
RITA (NSC 652287): Advancing Precision in p53 Activation
2026-04-22
Explore how RITA (NSC 652287) catalyzes a new era in translational cancer research by bridging mechanistic p53 pathway insights with actionable strategies for in vitro and in vivo validation. This article delivers scientific guidance for leveraging selective cytotoxicity and robust preclinical models, while uniquely elevating the discourse beyond standard product literature.
-
Bromodomain Inhibitor, (+)-JQ1: Workflows for BET Targeting
2026-04-22
Bromodomain Inhibitor, (+)-JQ1 enables high-precision modulation of BET proteins in cancer, inflammation, and male contraception research. This article provides optimized protocols, troubleshooting strategies, and actionable insights for advanced translational workflows.